BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 10963621)

  • 1. Estrogens as endogenous genotoxic agents--DNA adducts and mutations.
    Cavalieri E; Frenkel K; Liehr JG; Rogan E; Roy D
    J Natl Cancer Inst Monogr; 2000; (27):75-93. PubMed ID: 10963621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers: keynote lecture.
    Cavalieri E; Rogan E
    Ann N Y Acad Sci; 2006 Nov; 1089():286-301. PubMed ID: 17261777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity.
    Cavalieri E; Rogan E
    Mol Aspects Med; 2014 Apr; 36():1-55. PubMed ID: 23994691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotoxic effects of estrogens.
    Liehr JG
    Mutat Res; 1990 May; 238(3):269-76. PubMed ID: 2160607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is bisphenol A a weak carcinogen like the natural estrogens and diethylstilbestrol?
    Cavalieri EL; Rogan EG
    IUBMB Life; 2010 Oct; 62(10):746-51. PubMed ID: 20945454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention.
    Cavalieri E; Chakravarti D; Guttenplan J; Hart E; Ingle J; Jankowiak R; Muti P; Rogan E; Russo J; Santen R; Sutter T
    Biochim Biophys Acta; 2006 Aug; 1766(1):63-78. PubMed ID: 16675129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A unifying mechanism in the initiation of cancer and other diseases by catechol quinones.
    Cavalieri EL; Rogan EG
    Ann N Y Acad Sci; 2004 Dec; 1028():247-57. PubMed ID: 15650250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical depurinating DNA adducts: Estrogen adducts in the etiology and prevention of cancer and dopamine adducts in the etiology and prevention of Parkinson's disease.
    Cavalieri EL; Rogan EG; Zahid M
    Int J Cancer; 2017 Sep; 141(6):1078-1090. PubMed ID: 28388839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox cycling of catechol estrogens generating apurinic/apyrimidinic sites and 8-oxo-deoxyguanosine via reactive oxygen species differentiates equine and human estrogens.
    Wang Z; Chandrasena ER; Yuan Y; Peng KW; van Breemen RB; Thatcher GR; Bolton JL
    Chem Res Toxicol; 2010 Aug; 23(8):1365-73. PubMed ID: 20509668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo.
    Li KM; Todorovic R; Devanesan P; Higginbotham S; Köfeler H; Ramanathan R; Gross ML; Rogan EG; Cavalieri EL
    Carcinogenesis; 2004 Feb; 25(2):289-97. PubMed ID: 14578156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A unified mechanism in the initiation of cancer.
    Cavalieri EL; Rogan EG
    Ann N Y Acad Sci; 2002 Apr; 959():341-54. PubMed ID: 11976208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential mechanisms of estrogen quinone carcinogenesis.
    Bolton JL; Thatcher GR
    Chem Res Toxicol; 2008 Jan; 21(1):93-101. PubMed ID: 18052105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous estrogens as carcinogens through metabolic activation.
    Yager JD
    J Natl Cancer Inst Monogr; 2000; (27):67-73. PubMed ID: 10963620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The greater reactivity of estradiol-3,4-quinone vs estradiol-2,3-quinone with DNA in the formation of depurinating adducts: implications for tumor-initiating activity.
    Zahid M; Kohli E; Saeed M; Rogan E; Cavalieri E
    Chem Res Toxicol; 2006 Jan; 19(1):164-72. PubMed ID: 16411670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unbalanced metabolism of endogenous estrogens in the etiology and prevention of human cancer.
    Cavalieri EL; Rogan EG
    J Steroid Biochem Mol Biol; 2011 Jul; 125(3-5):169-80. PubMed ID: 21397019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initiation of cancer and other diseases by catechol ortho-quinones: a unifying mechanism.
    Cavalieri EL; Rogan EG; Chakravarti D
    Cell Mol Life Sci; 2002 Apr; 59(4):665-81. PubMed ID: 12022473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of the depurinating N3adenine and N7guanine adducts by reaction of DNA with hexestrol-3',4'-quinone or enzyme-activated 3'-hydroxyhexestrol. Implications for a unifying mechanism of tumor initiation by natural and synthetic estrogens.
    Saeed M; Gunselman SJ; Higginbotham S; Rogan E; Cavalieri E
    Steroids; 2005 Jan; 70(1):37-45. PubMed ID: 15610895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen, DNA damage and mutations.
    Roy D; Liehr JG
    Mutat Res; 1999 Mar; 424(1-2):107-15. PubMed ID: 10064854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catechol metabolites of endogenous estrogens induce redox cycling and generate reactive oxygen species in breast epithelial cells.
    Fussell KC; Udasin RG; Smith PJ; Gallo MA; Laskin JD
    Carcinogenesis; 2011 Aug; 32(8):1285-93. PubMed ID: 21665890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P450 isoforms catalyze formation of catechol estrogen quinones that react with DNA.
    Zhang Y; Gaikwad NW; Olson K; Zahid M; Cavalieri EL; Rogan EG
    Metabolism; 2007 Jul; 56(7):887-94. PubMed ID: 17570247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.